Copyright © Inderes 2011 - present. All rights reserved.
  • Senaste
  • Börs
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
  • inderesTV
  • Portfölj
  • Forum
  • Q&A
  • Om oss
    • Följda bolag
    • Teamet
Pressmeddelande

Redeye: AVTECH (Q3 Review) - Medium-term upside recognised

AVTECH Sweden

AVTECH’s sales grew 43% y/y, driven by new agreements, while USD/SEK was a small headwind. However, net sales and EBITDA were 11% and 9% below Redeye’s forecast, respectively (in line with the pre-announcement). Redeye revises its net sales estimate by 5% for 2025-2028, resulting in an 8-10% EBIT revision for the same period. Redeye reduces its Base Case by 8%. On Redeye’s updated EBIT estimates, AVTECH’s EV/EBIT NTM aligns with its 3-year average. Redeye views new agreements as the primary driver for the share, while the main risk consists of upcoming contract renewals in 2026.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments


AVTECH (Q3 Review) - Medium-term upside recognised

Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Ta kontakt
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • Om oss
  • Teamet
  • Jobba hos oss
  • Inderes som en investering
  • Tjänster för börsbolag
Vår plattform
  • FAQ
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer
Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.